Laura Cerchia

4.7k total citations
96 papers, 3.3k citations indexed

About

Laura Cerchia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Laura Cerchia has authored 96 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 20 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Laura Cerchia's work include Advanced biosensing and bioanalysis techniques (36 papers), RNA Interference and Gene Delivery (26 papers) and MicroRNA in disease regulation (12 papers). Laura Cerchia is often cited by papers focused on Advanced biosensing and bioanalysis techniques (36 papers), RNA Interference and Gene Delivery (26 papers) and MicroRNA in disease regulation (12 papers). Laura Cerchia collaborates with scholars based in Italy, France and Argentina. Laura Cerchia's co-authors include Vittorio de Franciscis, Monica Fedele, Simona Camorani, Carla Lucia Esposito, Gerolama Condorelli, Silvia Catuogno, Antonella Zannetti, Annamaria Guagliardi, Mosé Rossi and Guidalberto Manfioletti and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Laura Cerchia

95 papers receiving 3.3k citations

Peers

Laura Cerchia

ONCOL

IMMUN

Shinae Kizaka‐Kondoh Japan

Fabio Pastorino Italy

Vittorio de Franciscis Italy

Dinorah Friedmann‐Morvinski Israel

Arig Ibrahim‐Hashim United States

Rutong Yu China

Lu Liu China

Kasper Bendix Johnsen Denmark

Giovanna Peruzzi Italy

Mahaveer S. Bhojani United States

Shinae Kizaka‐Kondoh Japan

Laura Cerchia

2.3k ×0.9

1.3k ×1.8

784 ×1.4

ONCOL

934 ×1.8

363 ×1.0

IMMUN

Citations per year, relative to Laura Cerchia Laura Cerchia (= 1×) peers Shinae Kizaka‐Kondoh

Countries citing papers authored by Laura Cerchia

Since Specialization

Citations

This map shows the geographic impact of Laura Cerchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cerchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cerchia more than expected).

Fields of papers citing papers by Laura Cerchia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cerchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cerchia. The network helps show where Laura Cerchia may publish in the future.

Co-authorship network of co-authors of Laura Cerchia

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cerchia. A scholar is included among the top collaborators of Laura Cerchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cerchia. Laura Cerchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camorani, Simona, Luis Exequiel Ibarra, Gabriella Pinto, et al.. (2025). A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth. Bioactive Materials. 50. 443–460. 2 indexed citations

Tortorella, Silvia, Irene Locatelli, Erica Locatelli, et al.. (2025). Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease. Advanced Healthcare Materials. 14(10). e2403314–e2403314. 5 indexed citations

Oliver, Angela, Annachiara Sarnella, Maria Grazia Caprio, et al.. (2025). A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling. Cell Communication and Signaling. 23(1). 74–74. 6 indexed citations

Fedele, Monica, Laura Cerchia, & Sabrina Battista. (2024). Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression. Cells. 13(4). 350–350.

Agnello, Lisa, et al.. (2023). Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells. Cells. 12(13). 1809–1809. 6 indexed citations

Franco, Renato, Andrea Ronchi, Federica Zito Marino, et al.. (2023). PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype. Cancers. 15(7). 2190–2190. 8 indexed citations

Agnello, Lisa, et al.. (2023). Aptamer-Based Strategies to Boost Immunotherapy in TNBC. Cancers. 15(7). 2010–2010. 12 indexed citations

Sarnella, Annachiara, Sandra Albanese, Daniela Omodei, et al.. (2023). Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells. Cells. 12(2). 298–298. 12 indexed citations

Sarnella, Annachiara, Luigi Auletta, Sandra Albanese, et al.. (2022). Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. Journal of Experimental & Clinical Cancer Research. 41(1). 122–122. 38 indexed citations

10.

Fedele, Monica, Sabrina Battista, & Laura Cerchia. (2021). Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition. SHILAP Revista de lepidopterología. 2(4). 427–438. 3 indexed citations

11.

Camorani, Simona, Ilaria Granata, Francesca Collina, et al.. (2020). Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer. iScience. 23(4). 100979–100979. 23 indexed citations

12.

Camorani, Simona, Billy Samuel Hill, Francesca Collina, et al.. (2018). Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer. Theranostics. 8(18). 5178–5199. 51 indexed citations

13.

Valentino, Teresa, Marta De Menna, Elvira Crescenzi, et al.. (2016). PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells. Scientific Reports. 6(1). 25268–25268. 11 indexed citations

14.

Camorani, Simona & Laura Cerchia. (2015). Oligonucleotide Aptamers for Glioma Targeting: An Update. Central Nervous System Agents in Medicinal Chemistry. 15(2). 126–137. 13 indexed citations

15.

Camorani, Simona, Carla Lucia Esposito, Anna Di Rienzo, et al.. (2014). Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer. Molecular Therapy. 22(4). 828–841. 114 indexed citations

16.

Esposito, Carla Lucia, Laura Cerchia, Silvia Catuogno, et al.. (2014). Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy. Molecular Therapy. 22(6). 1151–1163. 138 indexed citations

17.

Esposito, Carla Lucia, Diana Passaro, Gerolama Condorelli, et al.. (2011). A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death. PLoS ONE. 6(9). e24071–e24071. 151 indexed citations

18.

D’Alessio, Amelia, Laura Cerchia, Ivano Amelio, et al.. (2007). Shp2 in PC12 cells: NGF versus EGF signalling. Cellular Signalling. 19(6). 1193–1200. 11 indexed citations

19.

Pestourie, Carine, Laura Cerchia, Karine Gombert, et al.. (2006). Comparison of Different Strategies to Select Aptamers Against a Transmembrane Protein Target. Oligonucleotides. 16(4). 323–335. 59 indexed citations

20.

Incoronato, Mariarosaria, Amelia D’Alessio, Simona Paladino, et al.. (2004). The Shp-1 and Shp-2, tyrosine phosphatases, are recruited on cell membrane in two distinct molecular complexes including Ret oncogenes. Cellular Signalling. 16(7). 847–856. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact